TrialArthritis research & therapy2019

A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers.

Vivek Nagaraja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.